Global Remifentanil Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Remifentanil Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
Remifentanil Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Remifentanil Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Endotracheal Intubation Operation and Neurosurgery are the major drivers for the industry.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remifentanil Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remifentanil Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remifentanil Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remifentanil Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Remifentanil Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remifentanil Hydrochloride introduction, etc. Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Remifentanil Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
Remifentanil Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Remifentanil Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Endotracheal Intubation Operation and Neurosurgery are the major drivers for the industry.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remifentanil Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remifentanil Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remifentanil Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remifentanil Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Remifentanil Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remifentanil Hydrochloride introduction, etc. Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Remifentanil Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices